An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's disease

S Cerri, F Blandini - Expert Opinion on Pharmacotherapy, 2020 - Taylor & Francis
Introduction Long-term treatment of Parkinson's disease (PD) with levodopa is hampered by
motor complications related to the inability of residual nigrostriatal neurons to convert …

Pramipexole and Lactoferrin ameliorate Cyclophosphamide-Induced haemorrhagic cystitis via targeting Sphk1/S1P/MAPK, TLR-4/NF-κB, and NLRP3/caspase-1/IL-1β …

NAA Baky, AH Al-Najjar, HA Elariny, AS Sallam… - International …, 2022 - Elsevier
Background The use of cyclophosphamide (CP) as a chemotherapeutic agent is limited by
its major complication haemorrhagic cystitis (HC). Finding preventive, safe, and efficient …

Reorienting of pramipexole as a promising therapy for acute pancreatitis in a rat model by suppressing TLR4\NF-κB p65\NLRP3 inflammasome signaling

HA Fawzy, AA Mohammed, HM Fawzy… - Canadian Journal of …, 2022 - cdnsciencepub.com
Acute pancreatitis (AP), a disorder of global importance, has a growing incidence and
prevalence, particularly in the Western world. Its complications include pseudocysts and …

[HTML][HTML] Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study

G Jîtcă, Z Gáll, CM Jîtcă, MG Buț, E Májai - Pharmaceutics, 2024 - mdpi.com
A particular attribute of the brain lies in the ability to learn, acquire information from the
environment, and utilize the learned information. Previous research has noted that various …

[HTML][HTML] Effects of different doses of dopamine receptor agonist pramipexole on neurobehaviors and changes of mitochondrial membrane potentials in rats with global …

X Kang, L Liu, W Wang, Y Wang - Journal of Stroke and Cerebrovascular …, 2023 - Elsevier
Objective To explore the effects of different doses of dopamine receptor agonist pramipexole
on neurobehaviors and changes of mitochondrial membrane potential in rats with global …